Multiple sclerosis in the Japanese population

Lancet Neurology

Volumn 2, Issue 2, 2003, Pages 117-127

  Kira, Jun Ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HLA DP ANTIGEN; HLA DPB1 ANTIGEN; HLA DR ANTIGEN; UNCLASSIFIED DRUG;

ASIA; BIRTH; BLOOD CHEMISTRY; BRAIN INJURY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CYTOTOXIC T LYMPHOCYTE; DIAGNOSTIC IMAGING; DISABILITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; ETHNIC GROUP; HLA SYSTEM; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; IMMUNOGENICITY; MULTIPLE SCLEROSIS; NOMENCLATURE; ONSET AGE; OPTIC NERVE DISEASE; PATHOPHYSIOLOGY; PLEOCYTOSIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RELAPSE; REMISSION; REVIEW; SEX DIFFERENCE; SPINAL CORD DISEASE; TH1 CELL; VALIDATION PROCESS; VERTEBRA; CLASSIFICATION; GENETICS; JAPAN; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

ASIA; HUMANS; JAPAN; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; TERMINOLOGY;

EID: 0042512328     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(03)00308-9     Document Type: Review

References (98)

1. Kuroiwa Y., Igata A., Itahara K., et al. Nationwide survey of multiple sclerosis in Japan: clinical analysis of 1,084 cases. Neurology. 25:1975;845-851.
2. Okinaka S., Tsubaki T., Kuroiwa Y., Toyokura Y., Imamura Y., Yoshikawa M. Multiple sclerosis and allied diseases in Japan: clinical characteristics. Neurology. 8:1958;756-763.
3. Kurtzke J.F., Park C.S., Oh S.J. Multiple sclerosis in Korea: clinical features and prevalence. J Neurol Sci. 6:1968;463-481.
4. Singhal B.S., Wadia N.H. Profile of multiple sclerosis in the Bombay region: on the basis of critical clinical appraisal. J Neurol Sci. 26:1975;259-270.
5. Hung T.P., Landsborough D., Hsi M.S. Multiple sclerosis amongst Chinese in Taiwan. J Neurol Sci. 27:1976;459-484.
6. Kuroiwa Y., Hung T.P., Landsborough D., et al. Multiple sclerosis in Asia. Neurology. 27:1977;188-192.
7. Naito S., Kuroiwa Y., Itoyama Y., et al. HLA and Japanese MS. Tissue Antigens. 12:1978;19-24.
8. Chopra J.S., Radhakrishnan K., Sawhney B.B., Pal S.R., Banerjee A.K. Multiple sclerosis in North-West India. Acta Neurol Scand. 62:1980;312-321.
9. Shibasaki H., McDonald W.I., Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J Neurol Sci. 49:1981;253-271.
10. Zhao B.X., Liu X.Q., Guo Y.P., Yang Y.C., Huang H. Multiple sclerosis: a clinical study of 70 cases. Eur Neurol. 20:1981;394-400.
11. Kuwajima J. On the cause of retrobulbar neuritis. Clin Ophthalmol (Rinshoganka). 4:1949;64-69 [in japanese].
12. Kira J., Kanai T., Nishimura Y., et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol. 40:1996;569-574.
13. Wingerchuk D.M., Hogancamp W.F., O'Brien P.C., Weinshenker B.G. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 53:1999;1107-1114.
14. Yu Y.L., Woo E., Hawkins B.R., Cho H.C., Huang C.Y. Multiple sclerosis amongst Chinese in Hong Kong. Brain. 112:1989;1445-1467.
15. Lau K.K., Wong L.K.S., Li L.S.W., Chan Y.W., Li H.L., Wong V. Epidemiological study of multiple sclerosis in Hong Kong Chinese: questionnaire survey. Hong Kong Med J. 8:2002;77-80.
16. Singhal B.S. Clinical profile and HLA-studies in Indian multiple sclerosis patients from the Bombay region. Kuroiwa Y., Kurland L.T. Multiple sclerosis East and West. 1982;123-134 Kyushu University Press, Fukuoka.
17. Kim S.W., Kim S.K. Multiple sclerosis in Busan, Korea: clinical features and prevalence. Kuroiwa Y., Kurland L.T. Multiple sclerosis East and West. 1982;57-70 Kyushu University Press, Fukuoka.
18. Tan C.T. Multiple sclerosis in Malaysia. Arch Neurol. 45:1988;624-627.
19. Vejjajiva A. Some clinical aspects of multiple sclerosis in Thai patients. Kuroiwa Y., Kurland L.T. Multiple sclerosis East and West. 1982;117-121 Kyushu University Press, Fukuoka.
20. Yaqub B.A., Daif A.K. Multiple sclerosis in Saudi Arabia. Neurology. 38:1988;621-623.
21. Al-Din A.S.N., Khogali M., Poser C.M., et al. Epidemiology of multiple sclerosis in Arabs in Kuwait: a comparative study between Kuwaitis and Palestinians. J Neurol Sci. 100:1990;137-141.
22. Al-Din A.S.N., El-Khateeb M., Kurdi A., et al. Multiple sclerosis in Arabs in Jordan. J Neurol Sci. 131:1995;144-149.
23. Wadia N.H., Bhatia K. Multiple sclerosis is prevalent in the Zoroastrians (Parsis) of India. Ann Neurol. 28:1990;177-179.
24. Kuroiwa Y., Shibasaki H., Ikeda M. Prevalence of multiple sclerosis and its north-to-south gradient in Japan. Neuroepidemiology. 2:1983;62-69.
25. Houzen H, Kikuchi S, Tashiro K, Matsumoto H, Epidemiological study of multiple sclerosis in Tokachi, Hokkaido. The 43rd Congress of Japanese Society of Neurology; 2002: (abstr II-F01; in Japanese).
26. Ito T, Takashita K, Katayama T, et al. Epidemiological study of multiple sclerosis in Asahikawa city. The 43rd Congress of Japanese Society of Neurology; 2002: (abstr P6-Q-04; in Japanese).
27. Kurtzke J.F. Epidemiologic contributions to multiple sclerosis: an overview. Neurology. 30:1980;61-79.
28. Hammond S.R., McLeod J.G., Millingen K.S., et al. The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Brain. 111:1988;1-25.
29. Fukazawa T., Kikuchi S., Sasaki H., et al. Genomic HLA profiles of MS in Hokkaido, Japan: important role of DPB1*0501 allele. J Neurol. 247:2000;175-178.
30. Nakashima I., Fujihara K., Okita N., Takase S., Itoyama Y. Clinical and MRI study of brain stem and cerebellar involvement in Japanese patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 67:1999;153-157.
31. Yamasaki K., Horiuchi I., Minohara M., et al. HLA-DPB1*0501- associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain. 122:1999;1689-1696.
32. Araki S., Uchino M., Yoshida O. Epidemiologic study of multiple sclerosis, myasthenia gravis, and polymyositis in the city of Kumamoto, Japan. Rinshoshinkeigaku. 23:1983;838-841 [in Japanese].
33. Shibasaki H., Okihiro M.M., Kuroiwa Y. Multiple sclerosis among Orientals and Caucasians in Hawaii: a reapparaisal. Neurology. 28:1978;113-118.
34. Mirsattari S.M., Johnston J.B., McKenna R., et al. Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica. Neurology. 56:2001;317-323.
35. Phillips P.H., Newman N.J., Lynn M.J. Optic neuritis in African Americans. Arch Neurol. 55:1998;186-192.
36. Osuntokun B.O. The pattern of neurological illness in tropical Africa: experience at Ibadan, Nigeria. J Neurol Sci. 12:1971;417-442.
37. Cabre P., Heinzlef O., Merle H., et al. MS and neuromyelitis optica in Martinique (French West Indies). Neurology. 56:2001;507-514.
38. Al-Din A.S.N., Al-Saffar M., Siboo R., Behbehani K. Association between HLA-D region epitopes and multiple sclerosis in Arabs. Tissue Antigens. 27:1986;196-200.
39. Saruhan-Direskeneli G., Esin S., Baykan-Kurt B., et al. HLA-DR and -DQ associations with multiple sclerosis in Turkey. Hum Immunol. 55:1997;59-65.
40. Hawkins B.R., Yu Y.L., Woo E., Huang C.Y. No apparent association between HLA and multiple sclerosis in southern Chinese. J Neurol Neurosurg Psychiatry. 51:1988;443-445.
41. Kelly M.A., Zhang Y., Penny M.A., et al. Genetic susceptibility to multiple sclerosis in a Shanghai Chinese population: the role of the HLA class II genes. Hum Immunol. 42:1995;203-208.
42. Spurkland A., Tabira T., Rønningen K.S., Vandvik B., Thorsby E., Vartdal F. HLA-DRB1, -DQA1, -DQB1, -DPA1 and -DPB1 genes in Japanese multiple sclerosis patients. Tissue Antigens. 37:1991;171-173.
43. Fukazawa T., Hamada T., Tashiro K., et al. HLA profiles of multiple sclerosis in Hokkaido, the northernmost island of Japan. Acta Neurol Scand. 86:1992;517-520.
44. Kalanie H., Kamgooyan M., Sadeghian H., Kalanie A.R. Histocompatibility antigen (HLA) associations with multiple sclerosis in Iran. Mult Scler. 6:2000;317-319.
45. Kálmán B., Takács K., Gyódi E., et al. Sclerosis multiplex in gypsies. Acta Neurol Scand. 84:1991;181-185.
46. Poser C.M., Paty D.W., Scheinberg L., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 133:1983;227-231.
47. Confavreux C., Vukusic S., Moreau T., Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med. 343:2000;1430-1438.
48. Fukazawa T., Moriwaka F., Sugiyama K., Hamada T., Tashiro K. Cerebrospinal fluid IgG profiles and multiple sclerosis in Japan. Acta Neurol Scand. 88:1993;178-183.
49. Nakashima I., Fujihara K., Itoyama Y. Oligoclonal IgG bands in Japanese multiple sclerosis patients. J Neuroimmunol. 101:1999;205-206.
50. Jain S., Maheshwari M.C. Multiple sclerosis: Indian experience in the last thirty years. Neuroepidemiology. 4:1985;96-107.
51. Al-Din A.S.N. Multiple sclerosis in Kuwait: clinical and epidemiological study. J Neurol Neurosurg Psychiatry. 49:1986;928-931.
52. Fukazawa T., Kikuchi S., Sasaki H., et al. The significance of oligoclonal bands in multiple sclerosis in Japan: relevance of immunogenetic backgrounds. J Neurol Sci. 158:1998;209-214.
53. Shiraki H., Yamamoto T., Hamada S. Pathoanatomical studies on neuromyelitis optica and demyelinating myelitis in Japan. Seishinshinkeigaku zasshi. 60:1958;1121-1157 [in Japanese].
54. Shiraki H. Neuropathological findings of demyelinating encephalomyelitides of unknown etiology in Japan. Saishin Igaku. 20:1965;1036-1052 [in Japanese].
55. Ikuta F., Koga M., Takeda S., et al. Comparison of MS pathology between 70 American and 75 Japanese autopsy cases. Kuroiwa Y., Kurland L.T. Multiple sclerosis east and west. 1982;298-306 Kyushu University Press, Fukuoka.
56. Tabira T., Tateishi J. Neuropathological features of MS in Japan. Kuroiwa Y., Kurland L.T. Multiple sclerosis east and west. 1982;273-295 Kyushu University Press, Fukuoka.
57. Dastur D.K., Singhal B.S. Two unusual neuropathologically proven cases of multiple sclerosis from Bombay. J Neurol Sci. 20:1973;397-414.
58. Mandler R.N., Davis L.E., Jeffery D.R., Kornfeld M. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol. 34:1993;162-168.
59. Silber M.H., Willcox P.A., Bowen R.M., Unger A. Neuromyelitis optica (Devic's syndrome) and pulmonary tuberculosis. Neurology. 40:1990;934-938.
60. Katz J.D., Ropper A.H. Progressive necrotic myelopathy: clinical course in 9 patients. Arch Neurol. 57:2000;355-361.
61. Olerup O., Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens. 38:1991;1-15.
62. Ma J.J., Nishimura M., Mine H., et al. HLA-DRB1 and tumor necrosis factor gene polymorphisms in Japanese patients with multiple sclerosis. J Neuroimmunol. 92:1998;109-112.
63. Fukazawa T., Yamasaki K., Ito H., et al. Both the HLA-DPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors. Tissue Antigens. 55:2000;199-205.
64. Ono T., Zambenedetti M.R., Yamasaki K., et al. Molecular analysis of HLA class I (HLA-A and -B) and HLA class II (HLA-DRB1) genes in Japanese patients with multiple sclerosis (western type and Asian type). Tissue Antigens. 52:1998;539-542.
65. Ito H., Yamasaki K., Kawano Y., et al. HLA-DP-associated susceptibility to the optico-spinal form of multiple sclerosis in the Japanese. Tissue Antigens. 52:1998;179-182.
66. Imanishi T., Akaza T., Kimura A., Tokunaga K., Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. Tsuji K., Aizawa M., Sasazuki T. HLA 1991: proceedings of the 11th international histocompatibility workshop and conference. 1992;1065-1220 Oxford University Press, Oxford.
67. Fukazawa T., Yanagawa T., Kikuchi S., et al. CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients. J Neurol Sci. 171:1999;49-55.
68. Fukazawa T., Yabe I., Kikuchi S., et al. Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J Neurol Sci. 166:1999;47-52.
69. Niino M., Kikuchi S., Fukazawa T., Yabe I., Tashiro K. No association of vitamin D-binding protein gene polymorphisms in Japanese patients with MS. J Neuroimmunol. 127:2002;177-179.
70. Niino M., Kikuchi S., Fukazawa T., Yabe I., Tashiro K. Estrogen receptor gene polymorphism in Japanese patients with multiple sclerosis. J Neurol Sci. 179:2000;70-75.
71. Kikuchi S., Fukazawa T., Niino M., et al. Estrogen receptor gene polymorphism and multiple sclerosis in Japanese patients: interaction with HLA-DRB1*1501 and disease modulation. J Neuroimmunol. 128:2002;77-81.
72. Niino M., Kikuchi S., Fukazawa T., Yabe I., Sasaki H., Tashiro K. Genetic polymorphisms of IL-1β and IL-1 receptor antagonist in association with multiple sclerosis in Japanese patients. J Neuroimmunol. 118:2001;295-299.
73. Niino M., Kikuchi S., Fukazawa T., Yabe I., Sasaki H., Tashiro K. Heat shock protein 70 gene polymorphism in Japanese patients with multiple sclerosis. Tissue Antigens. 58:2001;93-96.
74. Horiuchi I., Kawano Y., Yamasaki K., et al. Th1 dominance in HAM/TSP and the optico-spinal form of multiple sclerosis versus Th2 dominance in mite antigen-specific IgE myelitis. J Neurol Sci. 172:2000;17-24.
75. Ochi H., Wu X.-M., Osoegawa M., et al. Tc1/Tc2 and Th1/Th2 balance in Asian and Western types of multiple sclerosis, HTLV-I-associated myelopathy/tropical spastic paraparesis and hyperIgEaemic myelitis. J Neuroimmunol. 119:2001;297-305.
76. Wu X.-M., Osoegawa M., Yamasaki K., et al. Flow cytometric differentiation of Asian and Western types of multiple sclerosis, HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and hyperIgEaemic myelitis by analyses of memory CD4 positive T cell subsets and NK cell subsets. J Neurol Sci. 177:2000;24-31.
77. Kira J., Goto I. Recurrent opticomyelitis associated with anti-DNA antibody. J Neurol Neurosurg Psychiatry. 57:1994;1124-1125.
78. Fukazawa T., Moriwaka F., Mukai M., Hamada T., Koike T., Tashiro K. Anticardiolipin antibodies in Japanese patients with multiple sclerosis. Acta Neurol Scand. 88:1993;184-189.
79. Sakuma R., Fujihara K., Sato N., Mochizuki H., Itoyama Y. Optic-spinal form of multiple sclerosis and anti-thyroid autoantibodies. J Neurol. 246:1999;449-453.
80. Fukazawa T., Hamada T., Kikuchi S., Sasaki H., Tashiro K., Maguchi S. Antineutrophil cytoplasmic antibodies and the optic-spinal form of multiple sclerosis in Japan. J Neurol Neurosurg Psychiatry. 61:1996;203-204.
81. O'Riordan J.I., Gallagher H.L., Thompson A.J., et al. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry. 60:1996;382-387.
82. Vernant J.-C., Cabre P., Smadja D., et al. Recurrent optic neuromyelitis with endocrinopathies: a new syndrome. Neurology. 48:1997;58-64.
83. Minohara M., Ochi H., Matsushita S., Irie A., Nishimura Y., Kira J. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls. Tissue Antigens. 57:2001;447-456.
84. Misu T., Onodera H., Fujihara K., et al. Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling. J Neuroimmunol. 114:2001;207-212.
85. Mahad D.J., Howell S.J.L., Woodroofe M.N. Expression of chemokines in the CSF and correlation withclinical disease activity in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 72:2002;498-502.
86. Sørensen T.L., Tani M., Jensen J., et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest. 103:1999;807-815.
87. + T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci USA. 96:1999;6873-6878.
88. Simpson J.E., Newcombe J., Cuzner M.L., Woodroofe M.N. Expression of the interferon-β-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathol Appl Neurobiol. 26:2000;133-142.
89. Sørensen T.L., Trebst C., Kivisäkk P., et al. Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system. J Neuroimmunol. 127:2002;59-68.
90. Trebst C., Ransohoff R.M. Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challenges. Arch Neurol. 58:2001;1975-1980.
91. Compston A. Genetic epidemiology of multiple sclerosis. J Neurol Neurosurg Psychiatry. 62:1997;553-561.
92. Kira J., Yamasaki K., Horiuchi I., Ohyagi Y., Taniwaki T., Kawano Y. Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan. J Neurol Sci. 166:1999;53-57.
93. Nakashima I., Fujihara K., Takase S., Itoyama Y. Decrease in multiple sclerosis with acute transverse myelitis in Japan. Tohoku J Exp Med. 188:1999;89-94.
94. Midgard R., Riise T., Svanes C., Kvale G., Nyland H. Incidence of multiple sclerosis in More and Romsdal, Norway from 1950 to 1991: an age-period-cohort analysis. Brain. 119:1996;203-211.
95. Noonan C.W., Kathman S.J., White M.C. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology. 58:2002;136-138.
96. Hughes R.A.C., Mair W.G.P. Acute necrotic myelopathy with pulmonary tuberculosis. Brain. 100:1977;223-238.
97. Kuroiwa Y. Neuromyelitis optica (Devic's disease, Devic's syndrome). Vinken P.J., Bruyn G.W., Klawans H.L. Handbook of clinical neurology. 47:1985;397-408 Elsevier Science, Amsterdam.
98. Lucchinetti C.F., Mandler R.N., McGavern D., et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 125:2002;1450-1461.